Aside from PD-1 and CTLA-4, chronic inflammation in TME can result in upregulated expression of several other IC receptors contributing to immunosuppression and resistance of tumor cells to the antitumor activity of lymphocytes infiltrating the TME. The gene discussed is CTLA4; the disease is neoplasm.